JPRN-UMIN000028041
Recruiting
未知
The safety and efficacy of etelcalcetide for the treatment of secondary hyperparathyroidism compared with cinacalcet - The safety and efficacy of etelcalcetide compared with cinacalcet
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Patients on maintenance hemodialysis treated with cinacalcet for secondary hyperparathyroidism
- Sponsor
- Matsunami general hospital
- Enrollment
- 20
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
The safety and efficacy of etelcalcetide for the treatment of secondary hyperparathyroidism compared with cinacalcetPatients on maintenance hemodialysis treated with cinacalcet for secondary hyperparathyroidismJPRN-UMIN000027344Matsunami general hospital10
Recruiting
Phase 3
A Phase 3 Study of Etelcalcetide in Children With Secondary Hyperparathyroidism Receiving HemodialysisSecondary HyperparathyroidismNCT03969329Amgen24
Completed
Not Applicable
The beneficial effect and safety Eldecalcitol with combined peginterferon alpha-2a plus ribavirin for chronic hepatitis C patients with osteoporosisJPRN-UMIN000007070Department of Hepatology, Osaka City University Graduate School of Medicine50
Recruiting
Not Applicable
Efficacy and safety of etelcalcetide in hemodialysis patients with secondary hyperparathyroidism inadequately controlled with cinacalcetJPRN-UMIN000030568Jinken Clinic20
Completed
Phase 1
Safety, Tolerability and Pharmacokinetics of Etelcalcetide in Healthy Male VolunteersHyperparathyroidism, SecondaryNCT01134549KAI Pharmaceuticals32